Scientific article

Maladies hépatiques chroniques et diabète

Published inRevue médicale suisse, vol. 10, no. 433, p. 1254-1260
Publication date2014

The presence of chronic liver diseases may drastically limit the use of anti-diabetic drugs. Chronic liver diseases increase insulin resistance, and in some risk groups promote the development of diabetes. Therefore, antidiabetic treatment should be adapted to the severity of liver disease. However, diabetes, notably when associated with obesity and dyslipidemia, participates in the development of nonalcoholic fatty liver disease and to steato-hepatitis that may progress to cirrhosis and hepatocellular carcinoma. Other relations between diabetes and chronic liver disease will be discussed in this article. Finally, the indications and limits of each anti-diabetic therapy group will be discussed according to the degree of liver damage.

  • Blood Glucose/metabolism
  • Chronic Disease
  • Diabetes Mellitus, Type 2/drug therapy/etiology
  • Humans
  • Hypoglycemic Agents/administration & dosage/contraindications/therapeutic use
  • Liver Diseases/complications
Citation (ISO format)
JAAFAR, Jaafar et al. Maladies hépatiques chroniques et diabète. In: Revue médicale suisse, 2014, vol. 10, n° 433, p. 1254–1260.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation11/23/2015 2:31:00 PM
First validation11/23/2015 2:31:00 PM
Update time03/14/2023 11:58:22 PM
Status update03/14/2023 11:58:22 PM
Last indexation10/19/2023 12:24:52 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack